Aggregate Evidence Quality | Grade B |
Benefits | Reduce costs, unnecessary testing, and caregiver/infant anxiety |
Avoid consequences of false-positive results | |
Risks, harm, cost | May rarely miss an infant with recurrent central apnea or cardiac arrhythmias |
Benefit-harm assessment | The benefits of reducing unnecessary testing and false-positive results, as well as alleviating caregiver and infant anxiety, outweigh the rare missed diagnostic opportunity for recurrent apnea or cardiac arrhythmias |
Intentional vagueness | None |
Role of patient preferences | Caregivers will frequently request monitoring be instituted after an ALTE in their infant; a careful explanation of the limitations and disadvantages of this technology should be given |
Exclusions | None |
Strength | Moderate recommendation |
Key reference | 34 |
Aggregate Evidence Quality | Grade B |
Benefits | Reduce costs, unnecessary testing, and caregiver/infant anxiety |
Avoid consequences of false-positive results | |
Risks, harm, cost | May rarely miss an infant with recurrent central apnea or cardiac arrhythmias |
Benefit-harm assessment | The benefits of reducing unnecessary testing and false-positive results, as well as alleviating caregiver and infant anxiety, outweigh the rare missed diagnostic opportunity for recurrent apnea or cardiac arrhythmias |
Intentional vagueness | None |
Role of patient preferences | Caregivers will frequently request monitoring be instituted after an ALTE in their infant; a careful explanation of the limitations and disadvantages of this technology should be given |
Exclusions | None |
Strength | Moderate recommendation |
Key reference | 34 |